PRP and lidocaine

PreclinicalSmall molecule

TTanta University

PRP and lidocaine is one of 4 small molecule programs targeting Steroid Injection. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Steroid InjectionUnknown status

Steroid InjectionPreclinical

Unknown status

Competition

Competitive Landscape

4 competitors in Steroid Injection

#DrugCompanyPhaseTrials

Platelet Rich Plasma

ZZagazig University

Phase 3

1 2

PRP and lidocaine

TTanta University

Preclinical

1 3

Methylprednisolone Acetate and Lidocaine

TTanta University

Preclinical

1 4

Corticoids

PPoitiers University Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Steroid Injection1 trial

Comparison Between Ultrasound Guided Ozone, Platelet-Rich Plasma or Steroid Injection in the Treatment of Sacroiliitis; a Randomized Double Blinded Controlled Study

Unknown status·TTanta University·N/A·NCT05914350·105 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for PRP and lidocaine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — PRP and lidocaine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for PRP and lidocaine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Tanta University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: TTanta University

PRP and lidocaine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Steroid Injection1 trial

References

Drug Info

Quick Facts

Related News